Showing 341 - 360 results of 149,908 for search '(( a we decrease ) OR ( 5 ((wt decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.69s Refine Results
  1. 341

    The Transition from a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk by Heba M Ismail (9568748)

    Published 2022
    “…Conclusions</p> <p>A transition from an increase to a decrease in AUC C-peptide approximately 1.5 years pre-diagnosis was validated in two independent cohorts. …”
  2. 342
  3. 343
  4. 344
  5. 345
  6. 346
  7. 347

    Sinupret is a robust activator of CFTR-mediated and calcium-activated Cl<sup>-</sup> secretion. by Shaoyan Zhang (363713)

    Published 2014
    “…There were significant decreases in I<sub>SC</sub> when cultures were treated with CFTR inhibitor INH-172 in WT MNSE (−16.1+/−1.3 vs. −6.5+/−0.7, p<0.05) and HSNE cells (−17.0+/−1.6 vs. −11.1+/−1.7, p<0.05).…”
  8. 348
  9. 349
  10. 350
  11. 351

    <i>Mertk</i><sup><i>-/-</i></sup> macrophages exhibit unpolarized distribution of filamentous actin and myosin II, and decreased FAK phosphorylation. by Yong Tang (161879)

    Published 2015
    “…Scale bars in (A) and (B), 5 μm. (C) Western blotting shows decreased FAK phosphorylation at tyrosine 397 after addition of apoptotic T cells for the indicated time points. …”
  12. 352

    Simultaneous ablation of Syt1 and Syt7 decreases the RRP size at inhibitory synapses: Rescue by WT but not mutant Syt1 or Syt7. by Taulant Bacaj (803415)

    Published 2015
    “…Recordings were performed in the presence of 1 μM tetrodotoxin, 20 μM CNQX, and 50 μM AP5 to isolate inhibitory currents. <b>B.</b> Simultaneous ablation of Syt1 and Syt7 decreases the RRP size of inhibitory synapses in a manner that is rescued by WT Syt7 (Syt1<sup>WT</sup>) but not Syt7 with mutations in the top C2 domain sequences containing the Syt7 Ca<sup>2+</sup> binding sites (Syt7<sup>C2A</sup>*<sup>B</sup>*). …”
  13. 353
  14. 354

    Decreased levels of cathepsin Z mRNA expressed by immune blood cells: diagnostic and prognostic implications in prostate cancer by A.A.S. Batista (12656058)

    Published 2022
    “…Immune cells present in the blood of healthy patients overexpress CTSZ. In PCa, we found decreased CTSZ mRNA levels in blood cells, 75% lower than in healthy subjects, that diminished even more during biochemical relapse. …”
  15. 355
  16. 356
  17. 357
  18. 358
  19. 359
  20. 360